$2.56
0.062.40%
At close: -
$2.51
-0.05-1.95%
After Hours: Feb 11, 7:28 PM EDT
Comments
Loading...
CytoMed Therapeutics (NASDAQ:GDTC) Stock, Earnings Estimates, EPS, And Revenue
CytoMed Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of CytoMed Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
CytoMed Therapeutics (GDTC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
CytoMed Therapeutics (GDTC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is CytoMed Therapeutics (NASDAQ:GDTC) reporting earnings?
There are no earnings for CytoMed Therapeutics
What were the latest earnings per share (EPS) for CytoMed Therapeutics (NASDAQ:GDTC)?
There are no earnings for CytoMed Therapeutics
What were CytoMed Therapeutics’s (NASDAQ:GDTC) revenues?
There are no earnings for CytoMed Therapeutics
Browse earnings estimates, EPS, and revenue on all stocks.